Xenon Pharmaceuticals Inc. (XENE) stock
XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
$40.48−0.52 (-1.26%)
Close on Nov 13, 2026Market cap $3.92BP/E –Yield –
Xenon Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Xenon Pharmaceuticals's enterprise value was $3.14B on Nov 11, 2026, against $2.99B a year earlier. Over the last 5 years it ranged from $860.17M to $4.96B, with a median of $2.24B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.14B | +5.0% |
| 2025 | Dec 31, 2025 | $2.99B | +29.2% |
| 2024 | Dec 31, 2024 | $2.32B | -6.1% |
| 2023 | Dec 29, 2023 | $2.47B | +35.0% |
| 2022 | Dec 30, 2022 | $1.83B | +75.1% |
| 2021 | Dec 31, 2021 | $1.04B | +200.6% |
| 2020 | Dec 31, 2020 | $347.30M | +33.6% |
| 2019 | Dec 31, 2019 | $259.94M | +456.7% |
| 2018 | Dec 31, 2018 | $46.69M | +560.1% |
| 2017 | Dec 29, 2017 | $7.07M | -89.6% |
| 2016 | Dec 30, 2016 | $68.28M | +37.0% |
| 2015 | Dec 31, 2015 | $49.86M | – |
| 2014 | Dec 31, 2014 | -$21.28M | – |
See a number that looks wrong?